NuCicer Introduces Nuchi, announced Nuchi™ , a whole new class of high-protein chickpeas. Nuchi (“new + chickpea”) is the product of foundational plant genetics research accelerated by NuCicer's AI-driven genomic modeling and speed-breeding technology.
Alamar Biosciences, (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, launched the first commercial eMTBR-Tau immunoassay, now available in the NULISAseq™ Neuro 220 multiplexed panel kits, deployable on the installed base of ARGO™ HT instruments, and as a single-plex assay through the company’s Technology Access Program.
DeepSeq.AI announced the completion of an investment from Illumina Ventures. As part of the investment transaction, Martin Moorhead, PhD, Chief AI Scientist at Illumina Ventures, will join the DeepSeq board.
Support comes from new and existing investors, including life science, technology, growth, and sovereign wealth investors; Financing closely follows announcements of Iambic’s clinical data for IAM1363 at the ESMO Congress and entry into a clinical collaboration with Jazz Pharmaceuticals.
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
